Literature DB >> 20975570

HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection.

Jun Fu1, Beverly E Sha, Larry L Thomas.   

Abstract

OBJECTIVE: HIV-1 bound to intact neutrophils efficiently infects activated peripheral blood mononuclear cells (PBMC). Here, we evaluated the effect of the local milieu created by activated PBMC before and after HIV-1 infection on neutrophil survival and HLA-DR expression, with emphasis placed on a role for GM-CSF.
METHODS: PBMC of healthy adult individuals were activated by phytohemagglutinin (PHA) or anti-CD3/anti-CD28 and were subsequently cultured without (HIV-1⁻) or with HIV-1 (HIV-1+). The effects of the culture supernatants or recombinant GM-CSF on survival and HLA-DR expression by neutrophils of healthy adult individuals and of HIV-1-infected individuals were evaluated using flow cytometry.
RESULTS: Conditioned medium from PHA-activated PBMC (HIV-1⁻ and HIV-1+) increased neutrophil survival and induced HLA-DR expression by neutrophils of healthy individuals in a GM-CSF dependent fashion. HIV-1 infection variably, but consistently, increased GM-CSF production by PHA-activated PBMC but not GM-CSF production by anti-CD3/anti-CD28-activated PBMC. The latter was correlated with a loss of CD3+GMCSF+ cells after infection. Neutrophils of elite controllers exhibited a diminished HLADR response to GM-CSF in culture, whereas neutrophils of HIV-1+ subjects having a low viral load on anti-retroviral therapy or subjects with a high viral load exhibited a range of HLA-DR responses.
CONCLUSIONS: GM-CSF production within the mucosa or draining lymph nodes may promote HIV-1 infection by facilitating sustained contact between viable neutrophils with bound HIV-1 and CD4 lymphocytes. The minimal effect of GM-CSF on HLA-DR expression by neutrophils of elite controllers provides indirect support for this conclusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20975570      PMCID: PMC3640490          DOI: 10.1097/QAI.0b013e3181fa1fa5

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  45 in total

Review 1.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

2.  Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes.

Authors:  Valérie Abadie; Edgar Badell; Patrice Douillard; Danielle Ensergueix; Pieter J M Leenen; Myriam Tanguy; Laurence Fiette; Sem Saeland; Brigitte Gicquel; Nathalie Winter
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

3.  Lactoferrin. Antiviral activity of lactoferrin.

Authors:  P J Swart; E M Kuipers; C Smit; B W Van Der Strate; M C Harmsen; D K Meijer
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

4.  Acceleration of R5 HIV replication by polymorphonuclear neutrophils in cultures of macrophages.

Authors:  Tsuyoshi Yoshida; Vickie C Jones; Makiko Kobayashi; Xiao-Dong Li; Richard B Pollard; Fujio Suzuki
Journal:  Immunol Cell Biol       Date:  2007-01-09       Impact factor: 5.126

5.  Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation.

Authors:  M Radsak; C Iking-Konert; S Stegmaier; K Andrassy; G M Hänsch
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

6.  Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.

Authors:  F Colotta; F Re; N Polentarutti; S Sozzani; A Mantovani
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

Review 7.  GM-CSF in inflammation and autoimmunity.

Authors:  John A Hamilton
Journal:  Trends Immunol       Date:  2002-08       Impact factor: 16.687

8.  T-cell activation in human intestinal mucosa: the role of superantigens.

Authors:  J Aisenberg; E C Ebert; L Mayer
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

9.  Mucosal immunity to HIV: a review of recent literature.

Authors:  Barbara L Shacklett
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

10.  Depressed neutrophil superoxide production in human immunodeficiency virus infection.

Authors:  D L Pitrak; P M Bak; P DeMarais; R M Novak; B R Andersen
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

View more
  2 in total

Review 1.  Learning to Be Elite: Lessons From HIV-1 Controllers and Animal Models on Trained Innate Immunity and Virus Suppression.

Authors:  Sho Sugawara; R Keith Reeves; Stephanie Jost
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

Review 2.  Mucosal immunity in the female genital tract, HIV/AIDS.

Authors:  Juliana Reis Machado; Marcos Vinícius da Silva; Camila Lourencini Cavellani; Marlene Antônia dos Reis; Maria Luiza Gonçalves dos Reis Monteiro; Vicente de Paula Antunes Teixeira; Rosana Rosa Miranda Corrêa
Journal:  Biomed Res Int       Date:  2014-09-15       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.